Physician

David L Salko, MD

According to 2025 Medicare claims, David Salko, MD (NPI: 1659338879) practices family practice in the Lewiston-Auburn, ME market, with the plurality of this provider's patient population coming from Androscoggin, ME. This provider's primary affiliated billing organization is CENTRAL MAINE MEDICAL CENTER (NPI: 1689653487; TIN: 010211494) and primary practice location at 04086-1747. Salko is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), participating under the MSSP model.

Salko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 176 traditional Medicare patients, billed 501 HCPCS/CPT codes, and received $34,358 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 9,763 prescription claims across 818 beneficiaries totaling $987,451 in drug costs, led by Ozempic (Semaglutide). DME data shows 85 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $89,815 to $34,358. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $33,490 to $7,915.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	359	1,812	$89,815
2016	352	1,486	$74,571
2017	301	1,392	$70,352
2018	305	1,013	$54,819
2019	227	815	$46,458
2020	292	950	$54,502
2021	177	621	$45,761
2022	182	622	$43,127
2023	157	483	$33,317
2024	176	501	$34,358

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	479	14,492	$1,239,867
2016	547	13,021	$1,201,947
2017	524	13,047	$1,131,456
2018	616	11,206	$1,113,426
2019	520	8,755	$919,267
2020	608	8,838	$970,031
2021	605	8,711	$896,200
2022	599	8,981	$1,017,910
2023	578	9,208	$1,074,927
2024	818	9,763	$987,451

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	140	620	$29,581
2016	122	485	$17,606
2017	65	302	$11,451
2018	39	195	$3,727
2019	34	219	$4,006
2020	46	213	$5,672
2021	34	110	$2,370
2022	29	113	$2,973
2023	13	102	$1,814
2024	N/R	85	$4,750

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	89	89	$128
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	34	53	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	161	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	55	76	$42
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	35	43	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	110	3,646	$113,358
Trulicity	Dulaglutide	84	2,828	$92,286
Eliquis	Apixaban	44	3,029	$57,037
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	2,460	$48,846
Mounjaro	Tirzepatide	38	1,092	$41,441

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	15	$3,820
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	24	$385
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	15	$336
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	15	$185
A4259	Lancets, per box of 100	N	N/R	16	$23

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for David L. Salko, MD?

Tedicare shows public-source Medicare data for David L. Salko, MD (NPI 1659338879), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David L. Salko, MD have ACO affiliation data?

David L. Salko, MD is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290).

What billing organization is linked to David L. Salko, MD?

David L. Salko, MD is linked to CENTRAL MAINE MEDICAL CENTER (billing NPI 1689653487) in the available physician profile data.

Does David L. Salko, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.